Axbio
Axbio Biotechnology is a global leader in integrated circuit biotechnology, developing next-generation electrochemical detection platforms to transform life sciences tools and diagnostics. Their core technology includes a proprietary Bio-CMOS sequencing chip with millions of nanopore sequencing channels, enabling cost-effective, ultra-high throughput gene sequencing and molecular diagnostics. Key products include the AxiLona AXP-100 nanopore gene sequencer and the AxiLona EL-100 microarray analyzer, supported by a GMP production center and extensive R&D. The company integrates advanced synthetic biology, chemical engineering, electrochemical and microfluidic technologies, and AI-driven innovations to enhance sequencing accuracy, speed, and cost-efficiency. Axbio has global patent authorizations, a strong R&D team, and a presence in the US and China, positioning it as a pioneer in foundational life sciences platforms for research and clinical applications.
Axbio
Axbio Biotechnology is a global leader in integrated circuit biotechnology, developing next-generation electrochemical detection platforms to transform life sciences tools and diagnostics. Their core technology includes a proprietary Bio-CMOS sequencing chip with millions of nanopore sequencing channels, enabling cost-effective, ultra-high throughput gene sequencing and molecular diagnostics. Key products include the AxiLona AXP-100 nanopore gene sequencer and the AxiLona EL-100 microarray analyzer, supported by a GMP production center and extensive R&D. The company integrates advanced synthetic biology, chemical engineering, electrochemical and microfluidic technologies, and AI-driven innovations to enhance sequencing accuracy, speed, and cost-efficiency. Axbio has global patent authorizations, a strong R&D team, and a presence in the US and China, positioning it as a pioneer in foundational life sciences platforms for research and clinical applications.